Navigation Links
NxStage Awarded Multi-Year Contract to Supply Atlantic Dialysis Management Services with Vasc-Alert Access Surveillance Solution
Date:11/11/2011

LAWRENCE, Mass. and PHILADELPHIA, Nov. 11, 2011 /PRNewswire/ -- Booth # 407 at The American Society of Nephrology (ASN)'s Kidney Week 2011 -- NxStage® Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that its Medisystems division has won a multi-year contract to supply the Vasc-Alert™ Access Surveillance Solution to Atlantic Dialysis Management Services centers.

(Logo: http://photos.prnewswire.com/prnh/20110503/MM94799LOGO)

"Robust access surveillance is increasingly important for outcomes, center economics, and compliance under the new bundled payment system.  We believe Vasc-Alert's patented, automated technology simplifies and demonstrably improves a provider's ability to be effective in this area," said Mark Florence, Vice President & General Manager at Medisystems, a NxStage Company. "This agreement builds on a successful partnership between NxStage and Atlantic and demonstrates how Atlantic employs innovative new technology to improve patient care."

"After a thorough evaluation of Vasc-Alert, we believe we can reduce our rate of thrombectomy with this product technology," said J. Ganesh Bhat, M.D., Co-Principal, Atlantic Dialysis Management Services, L.L.C. "Vasc-Alert helps advance our goal of reducing hospitalizations and catheter usage. In addition, it provides a simple and convenient way to comply with CMS requirements for access surveillance without increasing staff workload."

About Vasc-Alert

Vasc-Alert, a patented medical device, uses computer technology to analyze standard treatment data taken during each patient's scheduled hemodialysis treatments to screen for vascular access dysfunction. By monitoring the data for increasing pressure trends, Vasc-Alert identifies patients who are at risk of developing a stenosis that may decrease the effectivene
'/>"/>

SOURCE NxStage Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. New FREEDOM Data Adds to Compelling Evidence in Support of More Frequent Home Hemodialysis with NxStage System One
2. NxStage Reports Record Third Quarter 2011 Financial Results and Raises Revenue Guidance For 2011
3. NxStage® Ranked Number 141 on the Fastest Growing Company in North America on Deloittes 2011 Technology Fast 500™
4. NxStage® to Report Third Quarter Fiscal 2011 Financial Results
5. NxStage Says Thank You to Patients and Care Partners at the 2nd Annual NxStageUsers Meet-Up and Conference in New Orleans
6. NxStage System One Patients Join Patient Advocacy Groups on Capitol Hill
7. NxStage Board Member Dr. Barry M. Straube Honored with Prestigious Award from the American Association of Kidney Patients
8. NxStage: NIH Study Published in New England Journal of Medicine Adds to Growing Body of Evidence in Support of More Frequent Hemodialysis
9. NxStage to Present at UBS Global Life Sciences Conference
10. NxStage Medical Founder and CEO Jeffrey Burbank Honored With Mass High Tech All-Star Award
11. Former NxStage System One User Celebrates One-Year Kidney Transplant Anniversary
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... BRAINTREE, Mass. , May 23, 2013  Haemonetics Corporation ... Chris Lindop , CFO & EVP-Business Development, will present ... Care Conference in Boston, MA on ... (Logo: http://photos.prnewswire.com/prnh/20120206/NE47232LOGO ) The public may ... About Haemonetics Haemonetics (NYSE: ...
(Date:5/23/2013)... PAUL, Minn. , May 23, 2013  MGC ... Corporation), a global medical technology company, today scheduled a ... second quarter of fiscal year 2013, ended April 30, ... on Thursday, May 30, 2013. The Company will report ... 2013 after the markets close on Thursday, May 30, ...
(Date:5/23/2013)... , May 23, 2013  Hadasit Bio-Holdings Ltd. ... of biotech companies, based on intellectual property developed ... Israel ,s foremost medical research center, today ... Ltd., received significant funding from the Israeli Ministry ... Scientist (OCS) to support product development and advance ...
Breaking Medicine Technology:MGC Diagnostics Corporation to Report Second Quarter Fiscal 2013 Financial Results on Thursday, May 30, 2013 2Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences Ltd. Received Additional Government Support 2
... April 19, 2011 Cumberland Pharmaceuticals Inc. ... focused on hospital acute care and gastroenterology markets, today ... acquire the rights to ifetroban, a new Phase II ... the brand name Hepatoren™ (ifetroban) Injection and is evaluating ...
... 18, 2011 Two lawsuits were filed today on ... have failed.  The cases were filed on behalf of ... DePuy Orthopaedics, Inc., DePuy Inc., DePuy International, Ltd., Johnson ... Johnson & Johnson International, Inc. John David Hart of ...
Cached Medicine Technology:Cumberland Pharmaceuticals Announces New Product Addition With Hepatoren™ (ifetroban) Injection 2Cumberland Pharmaceuticals Announces New Product Addition With Hepatoren™ (ifetroban) Injection 3Cumberland Pharmaceuticals Announces New Product Addition With Hepatoren™ (ifetroban) Injection 4Recalled DePuy Hip Implant Lawsuits Filed in Fort Worth, Texas 2
(Date:5/24/2013)... Teams of highly respected Alzheimer,s researchers failed to replicate ... of this brain disease when they were published last ... results, presented online Feb. 9, 2012, suggested that the ... buildup of beta amyloid plaques (Aβ) a pathological ... mice. According to the authors of the 2012 report, ...
(Date:5/24/2013)... Angeles, CA (PRWEB) May 24, 2013 ... to present the 3rd Annual EB-5 Investment Summit: Dealmakers ... The Dealmakers Conference will focus on exploring alternative finance ... the latest market, legal and economic information, and updates ... professionals within the EB-5 industry. , "Our goal ...
(Date:5/24/2013)... Mike Stoler believes that there is much to be ... York. That’s why he hosts “Building New York—New ... And that’s why he invited Robert Glazer, Chief Executive ... single specialty practice in the greater New York area, ... and sub-specialists service communities throughout New York and New ...
(Date:5/24/2013)... to the National Institutes of Health, Stevens Johnson Syndrome (SJS) ... the skin and mucous membranes. SJS occurs most commonly ... (i). In the early stages SJS presents flu-like symptoms, ... it affects the mucous membranes such as the eyes, mouth ... eye causes conjunctivitis (pink eye). Inflammation of the mouth ...
(Date:5/24/2013)... York, New York (PRWEB) May 24, 2013 ... 101 Mobility® is a leading nationwide sales, ... solutions for both consumer and commercial applications. The ... vertical platform lifts, vehicle lifts for mobility devices, ... among others. 101 Mobility operates over 30 locations, ...
Breaking Medicine News(10 mins):Health News:Multiple research teams unable to confirm high-profile Alzheimer's study 2Health News:Multiple research teams unable to confirm high-profile Alzheimer's study 3Health News:Brian Su Organizes 3rd Annual EB-5 Investment Conference in Long Beach, California 2Health News:Robert Glazer, Chief Executive Officer of ENT and Allergy Associates, LLP®, Talks About the Business of Succeeding in New York 2Health News:Robert Glazer, Chief Executive Officer of ENT and Allergy Associates, LLP®, Talks About the Business of Succeeding in New York 3Health News:Robert Glazer, Chief Executive Officer of ENT and Allergy Associates, LLP®, Talks About the Business of Succeeding in New York 4Health News:Personal Injury Law Firm Issues New Infographic Detailing a Potential Link Between Stevens Johnson Syndrome and Common Children’s Medicines 2Health News:Personal Injury Law Firm Issues New Infographic Detailing a Potential Link Between Stevens Johnson Syndrome and Common Children’s Medicines 3Health News:Cortec Closes Equity Transaction with 101 Mobility 2
... demand for transparency through publicly available healthcare data is on ... data for research, and for clinical trials data used to ... impact on research and policy making. A new report by ... Health Information at the University of Ottawa and the Children,s ...
... , THURSDAY, Sept. 15 (HealthDay News) -- Not enough ... the U.S. Centers for Disease Control and Prevention reveals. ... experts advise that although young people need the calcium, vitamin ... and older should consume low-fat milk and milk products to ...
... HealthDay Reporter , WEDNESDAY, Sept. 14 (HealthDay News) -- ... Republican presidential debate over the human papillomavirus vaccine for ... During the debate, Rep. Michele Bachmann of Minnesota ... girls in his state get the HPV vaccine to ...
... from breast and cervical cancer are rising in most countries, ... at younger ages, according to a new global analysis by ... University of Washington., Breast cancer cases more than doubled around ... 1980 to 1.6 million cases in 2010, a pace that ...
... , WEDNESDAY, Sept. 14 (HealthDay News) -- Most campaigns ... younger generations, excluding a large number of sexually active ... want this information, a new study suggests. , , ... older women are aware of the risks for sexually ...
... A Michigan State University professor is using a ... and socioeconomic disparities seen among health and medical researchers. ... of Medicine at MSU,s College of Human Medicine, will ... a short-term research education program aimed at under-represented, minority ...
Cached Medicine News:Health News:New report on creating clinical public use microdata files 2Health News:Not Enough Kids Drink Low-Fat Milk, U.S. Study Finds 2Health News:Health Experts Say HPV Vaccine Is Safe 2Health News:Health Experts Say HPV Vaccine Is Safe 3Health News:More women dying from breast and cervical cancer at a younger age in developing countries 2Health News:More women dying from breast and cervical cancer at a younger age in developing countries 3Health News:Older Women Can Benefit From Sex Ed Campaigns 2Health News:$1.1 million grant targets disparities among medical researchers 2
1.0 mm Micro System. The Titanium Micro System is also useful in the practice of ENT, Neurosurgery and Handsurgery....
... Codman Sofwire Cable ... bony fixation including sublaminar ... maxillo facial surgery, sternotomy ... cables and a complete ...
Specially designed combination of demineralized bone fibers and demineralized bone cubes that are both osteoinductive and osteoconductive. Packs well into bone defects. Eliminates the need to mix can...
Demineralized bone matrix dispensed in a syringe. DBM will be free of foreign matter. Demineralized bone matrix particle size 125 to 850 . Glycerol 70-88% by weight. Calcium content less than 8%....
Medicine Products: